Original article
Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet
Etelcalcetida controla el hiperparatiroidismo secundario y eleva los niveles de esclerostina en pacientes en hemodiálisis previamente no controlados con cinacalcet
Luciano Artur Lopes Pereiraa,b,c,
, Catarina Menga,b, Manuel Augusto Gonçalves Amoedod, Maria Teresa de Sousa Costa Pinto Ferreira Mendese, Marco Alexandre Mateus Prazeres Marquesf, João Miguel Machado Dória Frazãoa,b,c, André Luiz Loureiro Weigertg,h
Corresponding author
a Institute of Investigation and Innovation in Health, University of Porto, Portugal
b INEB – National Institute of Biomedical Engineering, University of Porto, Portugal
c Nephrology Department, Centro Hospitalar e Universitário de São João, Porto, Portugal
d Nephrology Department, Hospital Divino Espírito Santo, Évora, Portugal
e Nephrology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
f Affidea Laboratories, Portugal
g Nephrology Department, Hospital Santa Cruz, Carnaxide, Portugal
h Pharmacology Department, School of Medicine, University of Lisbon, Lisbon, Portugal
Read
1829
Timeswas read the article
843
Total PDF
986
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 4 | 2 | 6 |
| 2024 April | 61 | 63 | 124 |
| 2024 March | 47 | 49 | 96 |
| 2024 February | 35 | 58 | 93 |
| 2024 January | 26 | 54 | 80 |
| 2023 December | 35 | 38 | 73 |
| 2023 November | 79 | 48 | 127 |
| 2023 October | 70 | 61 | 131 |
| 2023 September | 65 | 48 | 113 |
| 2023 August | 139 | 61 | 200 |
| 2023 July | 104 | 73 | 177 |
| 2023 June | 82 | 29 | 111 |
| 2023 May | 40 | 34 | 74 |
| 2023 April | 25 | 34 | 59 |
| 2023 March | 32 | 36 | 68 |
| 2023 February | 33 | 46 | 79 |
| 2023 January | 35 | 51 | 86 |
| 2022 December | 58 | 45 | 103 |
| 2022 November | 16 | 13 | 29 |
Show all
